Teleflex Incorporated (NYSE:TFX) Stock Position Raised by Blue Trust Inc.

Blue Trust Inc. grew its position in shares of Teleflex Incorporated (NYSE:TFX) by 47.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 312 shares of the medical technology company’s stock after buying an additional 100 shares during the quarter. Blue Trust Inc.’s holdings in Teleflex were worth $77,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Teleflex by 1.8% in the first quarter. Vanguard Group Inc. now owns 5,550,727 shares of the medical technology company’s stock valued at $1,255,408,000 after acquiring an additional 96,711 shares during the last quarter. Janus Henderson Group PLC lifted its stake in shares of Teleflex by 12.0% in the 1st quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock valued at $1,223,424,000 after purchasing an additional 581,312 shares during the last quarter. Cooke & Bieler LP boosted its holdings in Teleflex by 23.3% in the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock worth $191,989,000 after purchasing an additional 172,335 shares in the last quarter. TD Asset Management Inc raised its holdings in Teleflex by 12.0% during the second quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company’s stock valued at $95,928,000 after buying an additional 48,832 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in Teleflex by 6.6% during the second quarter. Bank of New York Mellon Corp now owns 425,647 shares of the medical technology company’s stock valued at $89,526,000 after buying an additional 26,325 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

NYSE:TFX opened at $235.23 on Thursday. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.58 and a quick ratio of 1.44. The stock has a market cap of $11.08 billion, a P/E ratio of 42.23, a PEG ratio of 2.12 and a beta of 1.16. The company has a fifty day moving average price of $240.93 and a 200 day moving average price of $224.08. Teleflex Incorporated has a one year low of $178.83 and a one year high of $257.85.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, August 1st. The medical technology company reported $3.42 EPS for the quarter, topping the consensus estimate of $3.33 by $0.09. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. The firm had revenue of $749.70 million during the quarter, compared to analysts’ expectations of $762.98 million. During the same period last year, the business earned $3.41 earnings per share. Teleflex’s quarterly revenue was up .9% compared to the same quarter last year. Analysts anticipate that Teleflex Incorporated will post 13.97 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Stuart A. Randle sold 2,674 shares of the company’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the sale, the director now directly owns 5,496 shares in the company, valued at approximately $1,313,159.28. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 1.43% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on TFX shares. Truist Financial increased their price objective on Teleflex from $247.00 to $255.00 and gave the company a “hold” rating in a report on Monday, October 14th. Stephens lifted their price target on shares of Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. Finally, Royal Bank of Canada raised their target price on shares of Teleflex from $260.00 to $275.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, Teleflex has an average rating of “Moderate Buy” and a consensus target price of $268.86.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.